Mitchell H Rosner has a broad background in pharmaceuticals, biologics, device, food and nutritional supplements industries. His work at virtual and start-up companies and large multi-national entities has enabled him to provide value-added contributions at all types of organizations. He has contributed to 6 approved products and has multiple patents. Rosner has held several leadership positions in his career. He is a certified chemist (ACS), project manager (MPM through AAPM), HACCP manager (NEHA) and auditor (CQA and CBA through ASQ).
Rosner received his B.S. in chemistry from George Washington University (1982), a M.S. in toxicology (1985) and a Ph.D. in pharmacology and toxicology with a minor in pharmaceutical sciences (1989) from the University of Arizona. He began his career as a toxicologist but changed his scope of work to include analytical, formulation and process development, design of instrumentation, technology-transfer, validation, quality control and quality assurance.
Rosner began his industrial career as an analytical biochemist at IDEC Pharmaceuticals (now Biogen) and continued his applied analytical career at CV Therapeutics (now Gilead Sciences), Nektar Therapeutics and Novartis. His roles progressed from scientist to senior director including positions in quality control, analytical development and pharmaceutics. After serving as acting COO at an instrumentation start-up Infrasign, he joined Algenol Biofuels as Senior Director of Analytics and Bioinformatics and at Synthetic Genomics heading analytical chemistry and quality.